Category: W.L. Gore & Associates
The U.S. patent office takes a 1st pass at C.R. Bard's stent graft patent and finds it wanting, while an insurance arbitrator denies a $25 million insurance claim stemming from legal claims against its recalled hernia repair products.
C.R. Bard (NYSE:BCR) revealed a 1-2 punch today when it reported another loss in its patent infringement war with W.L. Gore & Assoc. and an adverse insurance decision that could cost it $25 million.
The U.S. Patent & Trademark Office grants W.L. Gore's bid to re-examine the C.R. Bard patents at the heart of a decades-long dispute over stent-graft technology.
W.L. Gore & Assoc. touts CE Mark approval in the European Union for lower-profile components for its Gore Excluder AAA endoprosthesis.
Arizona medical device maker W.L. Gore & Assoc. announced CE Mark approval in the European Union for new components of its Gore Excluder AAA endoprosthesis in treatment of abdominal aortic aneurysms.
European regulators cleared Gore's lower-profile 31 mm diameter ipsilateral leg and 32 mm aortic extender, designed for use with the Excluder AAA stent-graft in sealing off aneurysms and creating new paths for blood flow.
The U.S. Supreme Court refuses to hear an appeal from W.L. Gore & Assoc. in a patent war with C.R. Bard over stent graft technology.
The U.S. Supreme Court dashed the last hopes of W.L. Gore & Assoc. in its long-running patent war with C.R. Bard (NYSE:BCR) over vascular graft technology.
GI Dynamics and W.L. Gore & Assoc. settle their long-standing patent beef over GID's EndoBarrier weight loss device.
A long-running dispute between W.L Gore & Associates and GI Dynamics (ASX:GID) is over after the medical device companies agreed to settle the beef.
W.L. Gore & Associates wins CE Mark approval for its next- generation Excluder AAA endoprosthesis, featuring large diameter 35 mm trunk-ipsilateral legs and 36 mm aortic extender components.
Endotach LLC sues Medtronic, alleging infringement of a pair of patents covering stent graft technology by the medical device company's Talent, Valiant and Endurant devices.
Medtronic (NYSE:MDT) infringes a pair of patents licensed to Endotach LLC with 3 of its stent grafts for treating abdominal aortic aneurysms, according to a lawsuit filed by Endotach against the medtech titan.
The Frisco, Texas-based company holds the exclusive license to the duo of patents from their inventor's widow, according to court documents.
